NUTRIEN LTD (NTR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:NTR • CA67077M1086

70.395 USD
+1.7 (+2.48%)
Last: Feb 3, 2026, 02:56 PM
Fundamental Rating

5

NTR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. NTR has an average financial health and profitability rating. NTR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • NTR had positive earnings in the past year.
  • In the past year NTR had a positive cash flow from operations.
  • NTR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years NTR had a positive operating cash flow.
NTR Yearly Net Income VS EBIT VS OCF VS FCFNTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

  • NTR's Return On Assets of 3.49% is fine compared to the rest of the industry. NTR outperforms 71.08% of its industry peers.
  • The Return On Equity of NTR (7.20%) is better than 72.29% of its industry peers.
  • NTR has a Return On Invested Capital of 4.86%. This is in the better half of the industry: NTR outperforms 60.24% of its industry peers.
  • NTR had an Average Return On Invested Capital over the past 3 years of 8.34%. This is above the industry average of 6.11%.
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROIC 4.86%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
NTR Yearly ROA, ROE, ROICNTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • NTR has a better Profit Margin (6.79%) than 73.49% of its industry peers.
  • NTR's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.63%, NTR is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
  • NTR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 30.20%, NTR is in line with its industry, outperforming 54.22% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NTR has remained more or less at the same level.
Industry RankSector Rank
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
NTR Yearly Profit, Operating, Gross MarginsNTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NTR is destroying value.
  • Compared to 1 year ago, NTR has less shares outstanding
  • NTR has less shares outstanding than it did 5 years ago.
  • NTR has a worse debt/assets ratio than last year.
NTR Yearly Shares OutstandingNTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTR Yearly Total Debt VS Total AssetsNTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • NTR has an Altman-Z score of 1.89. This is not the best score and indicates that NTR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.89, NTR is in line with its industry, outperforming 51.81% of the companies in the same industry.
  • NTR has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as NTR would need 6.46 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.46, NTR is in the better half of the industry, outperforming 73.49% of the companies in the same industry.
  • A Debt/Equity ratio of 0.53 indicates that NTR is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.53, NTR is doing good in the industry, outperforming 62.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Altman-Z 1.89
ROIC/WACC0.41
WACC11.87%
NTR Yearly LT Debt VS Equity VS FCFNTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

  • NTR has a Current Ratio of 1.41. This is a normal value and indicates that NTR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.41, NTR is doing worse than 75.90% of the companies in the same industry.
  • A Quick Ratio of 0.89 indicates that NTR may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.89, NTR is doing worse than 68.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.89
NTR Yearly Current Assets VS Current LiabilitesNTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.48% over the past year.
  • Measured over the past years, NTR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.65% on average per year.
  • Looking at the last year, NTR shows a small growth in Revenue. The Revenue has grown by 0.25% in the last year.
  • The Revenue has been growing slightly by 5.28% on average over the past years.
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.03% on average over the next years.
  • The Revenue is expected to grow by 2.11% on average over the next years.
EPS Next Y36.09%
EPS Next 2Y17.01%
EPS Next 3Y9.12%
EPS Next 5Y6.03%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y2.11%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTR Yearly Revenue VS EstimatesNTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B
NTR Yearly EPS VS EstimatesNTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.42 indicates a rather expensive valuation of NTR.
  • 65.06% of the companies in the same industry are more expensive than NTR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.41, NTR is valued a bit cheaper.
  • NTR is valuated correctly with a Price/Forward Earnings ratio of 14.69.
  • NTR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NTR is cheaper than 66.27% of the companies in the same industry.
  • NTR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.42
Fwd PE 14.69
NTR Price Earnings VS Forward Price EarningsNTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NTR is valued a bit cheaper than 78.31% of the companies in the same industry.
  • 77.11% of the companies in the same industry are more expensive than NTR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.51
EV/EBITDA 7.67
NTR Per share dataNTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • NTR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NTR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.48
PEG (5Y)1.64
EPS Next 2Y17.01%
EPS Next 3Y9.12%

More info and screens

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.24%, NTR has a reasonable but not impressive dividend return.
  • NTR's Dividend Yield is a higher than the industry average which is at 2.27.
  • NTR's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

  • The dividend of NTR has a limited annual growth rate of 2.94%.
  • NTR has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of NTR decreased recently.
Dividend Growth(5Y)2.94%
Div Incr Years1
Div Non Decr Years1
NTR Yearly Dividends per shareNTR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 58.76% of the earnings are spent on dividend by NTR. This is a bit on the high side, but may be sustainable.
  • NTR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.76%
EPS Next 2Y17.01%
EPS Next 3Y9.12%
NTR Yearly Income VS Free CF VS DividendNTR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
NTR Dividend Payout.NTR Dividend Payout, showing the Payout Ratio.NTR Dividend Payout.PayoutRetained Earnings

More info and screens

NUTRIEN LTD

NYSE:NTR (2/3/2026, 2:56:07 PM)

70.395

+1.7 (+2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05
Earnings (Next)02-18
Inst Owners74.04%
Inst Owner Change-2.41%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap34.02B
Revenue(TTM)26.62B
Net Income(TTM)1.81B
Analysts72.59
Price Target49.1 (-30.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend2.15
Dividend Growth(5Y)2.94%
DP58.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.24%
Min EPS beat(2)0.97%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)-16.43%
Min EPS beat(4)-64.42%
Max EPS beat(4)9.5%
EPS beat(8)4
Avg EPS beat(8)-12.86%
EPS beat(12)4
Avg EPS beat(12)-17.39%
EPS beat(16)6
Avg EPS beat(16)-15.21%
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.9%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-3.94%
Revenue beat(12)4
Avg Revenue beat(12)-3.47%
Revenue beat(16)5
Avg Revenue beat(16)-2.55%
PT rev (1m)-0.8%
PT rev (3m)1.27%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)8.72%
EPS NY rev (1m)0.1%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 17.42
Fwd PE 14.69
P/S 1.28
P/FCF 15.51
P/OCF 8.19
P/B 1.35
P/tB 3.01
EV/EBITDA 7.67
EPS(TTM)4.04
EY5.74%
EPS(NY)4.79
Fwd EY6.81%
FCF(TTM)4.54
FCFY6.45%
OCF(TTM)8.59
OCFY12.21%
SpS55.08
BVpS51.97
TBVpS23.36
PEG (NY)0.48
PEG (5Y)1.64
Graham Number68.73
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROCE 8.09%
ROIC 4.86%
ROICexc 4.93%
ROICexgc 7.23%
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
FCFM 8.24%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
ROICexc(3y)8.53%
ROICexc(5y)7.25%
ROICexgc(3y)13.18%
ROICexgc(5y)11.36%
ROCE(3y)13.73%
ROCE(5y)11.62%
ROICexgc growth 3Y-18.22%
ROICexgc growth 5Y4.99%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y6.12%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Debt/EBITDA 2.31
Cap/Depr 81.9%
Cap/Sales 7.36%
Interest Coverage 4.41
Cash Conversion 72.18%
Profit Quality 121.28%
Current Ratio 1.41
Quick Ratio 0.89
Altman-Z 1.89
F-Score8
WACC11.87%
ROIC/WACC0.41
Cap/Depr(3y)112.14%
Cap/Depr(5y)101.14%
Cap/Sales(3y)7.97%
Cap/Sales(5y)7.55%
Profit Quality(3y)156.44%
Profit Quality(5y)184.5%
High Growth Momentum
Growth
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
EPS Next Y36.09%
EPS Next 2Y17.01%
EPS Next 3Y9.12%
EPS Next 5Y6.03%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y2.11%
EBIT growth 1Y19.73%
EBIT growth 3Y-15.31%
EBIT growth 5Y7.48%
EBIT Next Year100.07%
EBIT Next 3Y24.49%
EBIT Next 5Y14.07%
FCF growth 1Y-22.69%
FCF growth 3Y-13.08%
FCF growth 5Y-4.89%
OCF growth 1Y-26.52%
OCF growth 3Y-3.11%
OCF growth 5Y-0.72%

NUTRIEN LTD / NTR FAQ

What is the ChartMill fundamental rating of NUTRIEN LTD (NTR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NTR.


Can you provide the valuation status for NUTRIEN LTD?

ChartMill assigns a valuation rating of 6 / 10 to NUTRIEN LTD (NTR). This can be considered as Fairly Valued.


How profitable is NUTRIEN LTD (NTR) stock?

NUTRIEN LTD (NTR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for NTR stock?

The Price/Earnings (PE) ratio for NUTRIEN LTD (NTR) is 17.42 and the Price/Book (PB) ratio is 1.35.


What is the financial health of NUTRIEN LTD (NTR) stock?

The financial health rating of NUTRIEN LTD (NTR) is 4 / 10.